Emerald Acquisition’s American Renal Associates Holdings, Inc ARA Stock Holding History

Emerald Acquisition’s Portfolio ARA Stock Details ARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$353K	Buy	+19,305	New	+$435K	﹤0.01%	2560

Other funds holding ARA

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

Emerald Acquisition's ARA Position: Q3 2016 in Review

Emerald Acquisition opened a new position in American Renal Associates Holdings, Inc (ARA) in Q3 2016: 19,305 shares worth $353K. The stake represents ﹤0.01% of the portfolio and ranks #2560 among its holdings.

65 funds tracked by Wall St. Rank hold ARA as of Q3 2016.

Emerald Acquisition held 19,305 shares of American Renal Associates Holdings, Inc worth $353K as of Q3 2016.
American Renal Associates Holdings, Inc was a new Emerald Acquisition position in Q3 2016.
American Renal Associates Holdings, Inc made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2560 holding.
65 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.